Latest news

Dear Clients,   For safety reasons, Dekang has to cancel the following...
16 February 2017
Jan 1th, 2017 Recently, we have customer who claims that he has wired money to our bank account, but it turns out that we...
01 January 2017
Contact US  
16 December 2016
You are Here: Home >> News >> Industry News >> Can vaping help reversing diseases caused by smoki...
Can vaping help reversing diseases caused by smoking

QQ图片20161126163301

 

 In an interview published on Ashtray Blog, yesterday on the 24th of November, Professor Riccardo Polosa spoke about his findings in regards to the effects of vaping on individuals suffering from asthma and hypertension (high blood pressure).

Dr. Riccardo Polosa, MD, PhD, who is internationally recognized as a leader in the field of clinical broncho provocation (airway-challenge studies), is also author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction. He is also actively working to study and promote the benefits of e-cigarettes as effective smoking cessation tools, and safer alternatives to their combustible counterparts.

Improvements were noticed within six months

Polosa’s study subjects naturally reduced their cigarette consumption since they had taken up vaping. Naturally this reduction led to substantial health improvements, “In asthmatic patients, we observed significant and stable improvements in respiratory symptoms, disease exacerbation rates and lung function already after 6 months of regular e-cigarette use, and persisting for up to 2 years.”

He added by pointing out that in patients with high blood pressure, a reduction in systolic and diastolic BP was observed within six months of switching to vaping. When asked for details about how vaping may be contributing to this drop, and whether it’s just a direct effect of the decrease in smoking, the professor replied that aside from it being directly caused by the decrease in smoking, it is also attributed to the “the ritualistic and behavioural components associated with vaping”.

In asthmatic patients, we observed significant and stable improvements in respiratory symptoms, disease exacerbation rates and lung function, already after 6 months of regular e-cigarette use, and persisting for up to 2 years. - Dr. Riccardo Polosa

Additionally a positive aspect of quitting smoking via vaping is that this alleviates the anxiety and hypertension normally caused by abstinence.

Another important factor is that switching to vaping rather than quitting cold turkey has led to these patients not gaining the weight that is normally associated with curbing the habit. One could argue that this could be tied to the fact that they are still obtainingnicotine and the chemical has been found to play a significant role in weight control. Dr. Polosa pointed out that a healthy weight in turn leads to the maintenance of a healthy blood pressure.

Progress also noted in dual users

An advantage of switching to vaping rather than quitting cold turkey, is that these patients did not gain the weight that is normally associated with curbing the habit.

Polosa said that that the health improvements were not dramatic but clinically relevant. Interestingly he pointed out that these developments were not only evident in the respondents who switched to vaping completely, but a significant progress was also noticed in dual users. Asthma sufferers experienced less attacks, better control of symptoms and an improved sleep quality, while high blood pressure sufferers found that they are more relaxed and less anxious, hence observed an advancement in the social and psychological aspects of their life.

When asked why he picked these two conditions as an area of research, Dr. Polosa said that this was an obvious choice since he is responsible for several cardiovascular, metabolic and respiratory outpatient clinics, hence these patients were easy to follow and monitor.

Where will the research go from here?

Professor Polosa ended the interview by pointing out that now they will be moving on to studying the effects of vaping on patients suffering from COPD, (chronic obstructive pulmonary disease ), and diabetes. The medical director said that in his opinion the other areas worth exploring are those of chronic neurodegenerative disorders such as Alzheimer’s and Parkinson’s, and psychological illnesses, and concluded by expressing an interesting viewpoint, “Also, vaping should be re-evaluated in the light of its potential for administration of medical products with much improved adherence.”

Via Ashtray blog